应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
TRAW TRAWS PHARMA
已收盘 01-22 16:00:00 EST
2.49
+0.06
+2.47%
盘后
2.49
+0.00
0.00%
18:51 EST
最高
2.69
最低
2.36
成交量
20.89万
今开
2.45
昨收
2.43
日振幅
13.54%
总市值
1,990万
流通市值
1,475万
总股本
799.09万
成交额
53.21万
换手率
3.52%
流通股本
592.57万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
Traws Pharma, Inc.盘中异动 急速下挫5.59%
市场透视 · 01-15
Traws Pharma, Inc.盘中异动 急速下挫5.59%
Traws Pharma Inc:Ratutrelvir展现出与Paxlovid™的显著不同的特征,副作用更少且未出现病毒反弹
美股速递 · 2025-12-17
Traws Pharma Inc:Ratutrelvir展现出与Paxlovid™的显著不同的特征,副作用更少且未出现病毒反弹
TRAWS PHARMA公布Ratutrelvir与Paxlovid™对比的积极中期临床数据,显示对不适合使用Paxlovid患者的疗效
美股速递 · 2025-12-17
TRAWS PHARMA公布Ratutrelvir与Paxlovid™对比的积极中期临床数据,显示对不适合使用Paxlovid患者的疗效
Traws Pharma, Inc.盘中异动 早盘急速拉升6.17%
市场透视 · 2025-11-25
Traws Pharma, Inc.盘中异动 早盘急速拉升6.17%
Traws Pharma, Inc.盘中异动 快速拉升12.25%报2.19美元
市场透视 · 2025-11-10
Traws Pharma, Inc.盘中异动 快速拉升12.25%报2.19美元
Chemdiv扩展与TRAWS PHARMA的Ratutrelvir的CMC服务合作,后者是一个在进行二期临床试验的潜在最佳Covid-19治疗药物
美股速递 · 2025-10-31
Chemdiv扩展与TRAWS PHARMA的Ratutrelvir的CMC服务合作,后者是一个在进行二期临床试验的潜在最佳Covid-19治疗药物
TRAWS PHARMA启动Ratutrelvir二期新冠研究,首位患者已接受给药,预计2025年底公布结果
美股速递 · 2025-10-14
TRAWS PHARMA启动Ratutrelvir二期新冠研究,首位患者已接受给药,预计2025年底公布结果
TRAWS PHARMA任命John Leaman医学博士为独立董事,并正式确认两名核心高管职务
美股速递 · 2025-10-06
TRAWS PHARMA任命John Leaman医学博士为独立董事,并正式确认两名核心高管职务
Traws Pharma, Inc.盘中异动 股价大涨6.67%报1.60美元
市场透视 · 2025-08-12
Traws Pharma, Inc.盘中异动 股价大涨6.67%报1.60美元
Traws Pharma, Inc.盘中异动 大幅拉升5.56%
市场透视 · 2025-08-08
Traws Pharma, Inc.盘中异动 大幅拉升5.56%
Traws Pharma, Inc.盘中异动 下午盘急速上涨5.48%报1.54美元
市场透视 · 2025-08-05
Traws Pharma, Inc.盘中异动 下午盘急速上涨5.48%报1.54美元
Traws Pharma, Inc.盘中异动 早盘股价大跌5.19%
市场透视 · 2025-08-01
Traws Pharma, Inc.盘中异动 早盘股价大跌5.19%
Traws Pharma, Inc.盘中异动 股价大涨5.01%报1.64美元
市场透视 · 2025-07-31
Traws Pharma, Inc.盘中异动 股价大涨5.01%报1.64美元
Traws Pharma, Inc.盘中异动 股价大跌5.30%
市场透视 · 2025-03-10
Traws Pharma, Inc.盘中异动 股价大跌5.30%
Traws Pharma, Inc.盘中异动 快速拉升5.05%
市场透视 · 2025-03-06
Traws Pharma, Inc.盘中异动 快速拉升5.05%
Traws Pharma, Inc.盘中异动 早盘股价大涨6.69%
市场透视 · 2025-03-05
Traws Pharma, Inc.盘中异动 早盘股价大涨6.69%
Traws Pharma, Inc.盘中异动 股价大跌6.95%
市场透视 · 2025-03-03
Traws Pharma, Inc.盘中异动 股价大跌6.95%
Traws Pharma, Inc.盘中异动 早盘大幅下挫5.17%
市场透视 · 2025-02-28
Traws Pharma, Inc.盘中异动 早盘大幅下挫5.17%
Traws Pharma, Inc.盘中异动 大幅拉升10.00%报3.85美元
市场透视 · 2025-02-26
Traws Pharma, Inc.盘中异动 大幅拉升10.00%报3.85美元
Traws Pharma, Inc.盘中异动 早盘股价大涨5.00%
市场透视 · 2025-02-25
Traws Pharma, Inc.盘中异动 早盘股价大涨5.00%
加载更多
公司概况
公司名称:
TRAWS PHARMA
所属市场:
NASDAQ
上市日期:
--
主营业务:
Traws Pharma, Inc.于1998年12月22日在特拉华州注册成立,于1999年1月1日开始运营,是一家临床阶段的生物制药公司,专注于发现和开发治疗癌症的新型小分子候选药物。Traws正在开发用于流感、COVID和其他呼吸道感染的下一代、同类最佳的抗病毒药物,以及用于肿瘤学的narazaciclib。
发行价格:
--
{"stockData":{"symbol":"TRAW","market":"US","secType":"STK","nameCN":"TRAWS PHARMA","latestPrice":2.49,"timestamp":1769115600000,"preClose":2.43,"halted":0,"volume":208868,"hourTrading":{"tag":"盘后","latestPrice":2.49,"preClose":2.49,"latestTime":"18:51 EST","volume":164,"amount":410.14,"timestamp":1769125901085,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.024691358024691377,"floatShares":5925700,"shares":7990867,"eps":-1.82,"marketStatus":"已收盘","change":0.06,"latestTime":"01-22 16:00:00 EST","open":2.45,"high":2.689,"low":2.36,"amount":532052.9236087999,"amplitude":0.135391,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.82,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1769158800000},"marketStatusCode":5,"adr":0,"listingDate":1374724800000,"exchange":"NASDAQ","adjPreClose":2.43,"preHourTrading":{"tag":"盘前","latestPrice":2.34,"preClose":2.43,"latestTime":"09:20 EST","volume":58,"amount":136.3315926,"timestamp":1769091637065,"change":-0.09,"changeRate":-0.037037,"amplitude":0.032922},"postHourTrading":{"tag":"盘后","latestPrice":2.49,"preClose":2.49,"latestTime":"18:51 EST","volume":164,"amount":410.14,"timestamp":1769125901085,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.289709,"impliedVol":1.6331,"impliedVolPercentile":0},"requestUrl":"/m/hq/s/TRAW","defaultTab":"news","newsList":[{"id":"2603603079","title":"Traws Pharma, Inc.盘中异动 急速下挫5.59%","url":"https://stock-news.laohu8.com/highlight/detail?id=2603603079","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603603079?lang=zh_cn&edition=full","pubTime":"2026-01-15 01:14","pubTimestamp":1768410894,"startTime":"0","endTime":"0","summary":"北京时间2026年01月15日01时14分,Traws Pharma, Inc.股票出现波动,股价快速下挫5.59%。Traws Pharma, Inc.股票所在的生物技术行业中,整体跌幅为0.07%。Traws Pharma, Inc.公司简介:Traws Pharma Inc 是一家临床阶段的生物制药公司,致力于开发新型疗法,以针对呼吸道病毒性疾病对人类健康的关键威胁。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260115011454953ccbb7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260115011454953ccbb7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TRAW","BK4007"],"gpt_icon":0},{"id":"1105664831","title":"Traws Pharma Inc:Ratutrelvir展现出与Paxlovid™的显著不同的特征,副作用更少且未出现病毒反弹","url":"https://stock-news.laohu8.com/highlight/detail?id=1105664831","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1105664831?lang=zh_cn&edition=full","pubTime":"2025-12-17 19:12","pubTimestamp":1765969962,"startTime":"0","endTime":"0","summary":"Traws Pharma Inc:Ratutrelvir展现出与Paxlovid™的显著不同的特征,副作用更少且未出现病毒反弹","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TRAW","BK4007"],"gpt_icon":0},{"id":"1177639705","title":"TRAWS PHARMA公布Ratutrelvir与Paxlovid™对比的积极中期临床数据,显示对不适合使用Paxlovid患者的疗效","url":"https://stock-news.laohu8.com/highlight/detail?id=1177639705","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1177639705?lang=zh_cn&edition=full","pubTime":"2025-12-17 19:12","pubTimestamp":1765969951,"startTime":"0","endTime":"0","summary":"TRAWS PHARMA公布Ratutrelvir与Paxlovid™的对比数据,展示其在不适合使用Paxlovid的COVID-19患者中具有积极的疗效。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TRAW","BK4007"],"gpt_icon":0},{"id":"2586287406","title":"Traws Pharma, Inc.盘中异动 早盘急速拉升6.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2586287406","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586287406?lang=zh_cn&edition=full","pubTime":"2025-11-25 23:17","pubTimestamp":1764083863,"startTime":"0","endTime":"0","summary":"北京时间2025年11月25日23时17分,Traws Pharma, Inc.股票出现波动,股价大幅拉升6.17%。Traws Pharma, Inc.股票所在的生物技术行业中,整体涨幅为0.19%。Traws Pharma, Inc.公司简介:Traws Pharma Inc 是一家临床阶段的生物制药公司,致力于开发新型疗法,以针对呼吸道病毒性疾病对人类健康的关键威胁。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251125231743a710ed57&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251125231743a710ed57&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TRAW","BK4007"],"gpt_icon":0},{"id":"2582361182","title":"Traws Pharma, Inc.盘中异动 快速拉升12.25%报2.19美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2582361182","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582361182?lang=zh_cn&edition=full","pubTime":"2025-11-10 22:39","pubTimestamp":1762785575,"startTime":"0","endTime":"0","summary":"北京时间2025年11月10日22时39分,Traws Pharma, Inc.股票出现异动,股价快速拉升12.25%。Traws Pharma, Inc.股票所在的生物技术行业中,整体涨幅为0.67%。其相关个股中,Cogent Biosciences, Inc.、Inflarx N.V.、Pluri Inc.涨幅较大,Inflarx N.V.、Propanc Biopharma, Inc.、Innate Pharma较为活跃,换手率分别为78.46%、15.30%、8.72%,振幅较大的相关个股有Jasper Therapeutics Inc C/Wts 24/09/2026 、Cogent Biosciences, Inc.、Pluri Inc.,振幅分别为22.10%、20.18%、20.06%。Traws Pharma, Inc.公司简介:Traws Pharma Inc 是一家临床阶段的生物制药公司,致力于开发新型疗法,以针对呼吸道病毒性疾病对人类健康的关键威胁。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025111022393594fb9650&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025111022393594fb9650&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TRAW","BK4007"],"gpt_icon":0},{"id":"1157882863","title":"Chemdiv扩展与TRAWS PHARMA的Ratutrelvir的CMC服务合作,后者是一个在进行二期临床试验的潜在最佳Covid-19治疗药物","url":"https://stock-news.laohu8.com/highlight/detail?id=1157882863","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1157882863?lang=zh_cn&edition=full","pubTime":"2025-10-31 00:00","pubTimestamp":1761840050,"startTime":"0","endTime":"0","summary":"Chemdiv扩展与TRAWS PHARMA的Ratutrelvir的CMC服务合作,后者是一个在进行二期临床试验的潜在最佳Covid-19治疗药物","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TRAW","BK4007"],"gpt_icon":0},{"id":"1184440960","title":"TRAWS PHARMA启动Ratutrelvir二期新冠研究,首位患者已接受给药,预计2025年底公布结果","url":"https://stock-news.laohu8.com/highlight/detail?id=1184440960","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1184440960?lang=zh_cn&edition=full","pubTime":"2025-10-14 19:00","pubTimestamp":1760439648,"startTime":"0","endTime":"0","summary":"TRAWS PHARMA启动Ratutrelvir二期新冠研究,首位患者已接受给药,预计2025年底公布结果","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","TRAW"],"gpt_icon":0},{"id":"1119026861","title":"TRAWS PHARMA任命John Leaman医学博士为独立董事,并正式确认两名核心高管职务","url":"https://stock-news.laohu8.com/highlight/detail?id=1119026861","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1119026861?lang=zh_cn&edition=full","pubTime":"2025-10-06 19:02","pubTimestamp":1759748565,"startTime":"0","endTime":"0","summary":"TRAWS PHARMA任命John Leaman医学博士为独立董事,并正式确认两名核心高管职务","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","TRAW"],"gpt_icon":0},{"id":"2558664872","title":"Traws Pharma, Inc.盘中异动 股价大涨6.67%报1.60美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2558664872","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558664872?lang=zh_cn&edition=full","pubTime":"2025-08-12 00:08","pubTimestamp":1754928511,"startTime":"0","endTime":"0","summary":"北京时间2025年08月12日00时08分,Traws Pharma, Inc.股票出现异动,股价急速拉升6.67%。Traws Pharma, Inc.股票所在的生物技术行业中,整体涨幅为0.42%。其相关个股中,Equillium, Inc.、Entero Therapeutics Inc.、Aspire Biopharma Holdings Inc C/Wts 14/02/2030 涨幅较大,Entero Therapeutics Inc.、Equillium, Inc.、Bioxcel Therapeutics, Inc.较为活跃,换手率分别为5806.00%、551.72%、187.82%,振幅较大的相关个股有Equillium, Inc.、Entero Therapeutics Inc.、Jyong Biotech Ltd.,振幅分别为84.05%、74.27%、62.69%。Traws Pharma, Inc.公司简介:Traws Pharma Inc 是一家临床阶段的生物制药公司,致力于开发新型疗法,以针对呼吸道病毒性疾病对人类健康的关键威胁。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250812000831a4824c9a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250812000831a4824c9a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TRAW","BK4007"],"gpt_icon":0},{"id":"2557357868","title":"Traws Pharma, Inc.盘中异动 大幅拉升5.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2557357868","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557357868?lang=zh_cn&edition=full","pubTime":"2025-08-08 22:15","pubTimestamp":1754662557,"startTime":"0","endTime":"0","summary":"北京时间2025年08月08日22时15分,Traws Pharma, Inc.股票出现波动,股价急速拉升5.56%。Traws Pharma, Inc.股票所在的生物技术行业中,整体跌幅为0.48%。Traws Pharma, Inc.公司简介:Traws Pharma Inc 是一家临床阶段的生物制药公司,致力于开发新型疗法,以针对呼吸道病毒性疾病对人类健康的关键威胁。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250808221557973bf3ec&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250808221557973bf3ec&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TRAW","BK4007"],"gpt_icon":0},{"id":"2557335033","title":"Traws Pharma, Inc.盘中异动 下午盘急速上涨5.48%报1.54美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557335033","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557335033?lang=zh_cn&edition=full","pubTime":"2025-08-05 02:38","pubTimestamp":1754332737,"startTime":"0","endTime":"0","summary":"北京时间2025年08月05日02时38分,Traws Pharma, Inc.股票出现波动,股价快速上涨5.48%。Traws Pharma, Inc.股票所在的生物技术行业中,整体涨幅为1.38%。Traws Pharma, Inc.公司简介:Traws Pharma Inc 是一家临床阶段的生物制药公司,致力于开发新型疗法,以针对呼吸道病毒性疾病对人类健康的关键威胁。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250805023857a474e98f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250805023857a474e98f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TRAW","BK4007"],"gpt_icon":0},{"id":"2556178038","title":"Traws Pharma, Inc.盘中异动 早盘股价大跌5.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2556178038","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2556178038?lang=zh_cn&edition=full","pubTime":"2025-08-01 22:11","pubTimestamp":1754057474,"startTime":"0","endTime":"0","summary":"北京时间2025年08月01日22时11分,Traws Pharma, Inc.股票出现异动,股价快速下跌5.19%。Traws Pharma, Inc.股票所在的生物技术行业中,整体跌幅为0.07%。Traws Pharma, Inc.公司简介:Traws Pharma Inc 是一家临床阶段的生物制药公司,致力于开发新型疗法,以针对呼吸道病毒性疾病对人类健康的关键威胁。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250801221114a46ff1b3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250801221114a46ff1b3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","TRAW"],"gpt_icon":0},{"id":"2555261810","title":"Traws Pharma, Inc.盘中异动 股价大涨5.01%报1.64美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2555261810","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555261810?lang=zh_cn&edition=full","pubTime":"2025-07-31 02:00","pubTimestamp":1753898417,"startTime":"0","endTime":"0","summary":"北京时间2025年07月31日02时00分,Traws Pharma, Inc.股票出现异动,股价大幅上涨5.01%。截至发稿,该股报1.64美元/股,成交量8.2203万股,换手率1.48%,振幅5.77%。Traws Pharma, Inc.股票所在的生物技术行业中,整体涨幅为0.67%。Traws Pharma, Inc.公司简介:Traws Pharma Inc 是一家临床阶段的生物制药公司,致力于开发新型疗法,以针对呼吸道病毒性疾病对人类健康的关键威胁。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507310200179728495a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507310200179728495a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TRAW","BK4007"],"gpt_icon":0},{"id":"2518475278","title":"Traws Pharma, Inc.盘中异动 股价大跌5.30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518475278","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518475278?lang=zh_cn&edition=full","pubTime":"2025-03-10 22:22","pubTimestamp":1741616551,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日22时22分,Traws Pharma, Inc.股票出现波动,股价快速跳水5.30%。Traws Pharma, Inc.股票所在的生物技术行业中,整体涨幅为0.47%。其相关个股中,Checkpoint Therapeutics, Inc.、Mineralys Therapeutics, Inc.、Aeon Biopharma, Inc.涨幅较大,Biodexa Pharmaceuticals Plc、Scisparc Ltd.、Dogwood Therapeutics, Inc.较为活跃,换手率分别为3401.51%、720.06%、414.27%,振幅较大的相关个股有Dogwood Therapeutics, Inc.、Scisparc Ltd.、Biodexa Pharmaceuticals Plc,振幅分别为41.36%、40.24%、39.34%。Traws Pharma, Inc.公司简介:Traws Pharma Inc 是一家生物制药公司,专注于开发流感、COVID和其他呼吸道感染的抗病毒药物和narazaciclib。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031022223196404282&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031022223196404282&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TRAW","BK4007"],"gpt_icon":0},{"id":"2517161983","title":"Traws Pharma, Inc.盘中异动 快速拉升5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517161983","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517161983?lang=zh_cn&edition=full","pubTime":"2025-03-06 23:13","pubTimestamp":1741274023,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日23时13分,Traws Pharma, Inc.股票出现异动,股价急速上涨5.05%。Traws Pharma, Inc.股票所在的生物技术行业中,整体跌幅为0.32%。其相关个股中,Aeon Biopharma, Inc.、Cardio Diagnostics Holdings Inc C/Wts To Pur Com、Plus Therapeutics, Inc.涨幅较大,Plus Therapeutics, Inc.、Aeon Biopharma, Inc.、Aditxt, Inc.较为活跃,换手率分别为1510.12%、905.97%、76.46%,振幅较大的相关个股有Aeon Biopharma, Inc.、Cardio Diagnostics Holdings Inc C/Wts To Pur Com、Moolec Science Sa C/Wts ,振幅分别为56.82%、44.64%、44.44%。Traws Pharma, Inc.公司简介:Traws Pharma Inc 是一家生物制药公司,专注于开发流感、COVID和其他呼吸道感染的抗病毒药物和narazaciclib。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306231343963c5603&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306231343963c5603&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TRAW","BK4007"],"gpt_icon":0},{"id":"2517910578","title":"Traws Pharma, Inc.盘中异动 早盘股价大涨6.69%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517910578","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517910578?lang=zh_cn&edition=full","pubTime":"2025-03-05 22:30","pubTimestamp":1741185027,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日22时30分,Traws Pharma, Inc.股票出现波动,股价急速拉升6.69%。Traws Pharma, Inc.股票所在的生物技术行业中,整体涨幅为0.00%。其相关个股中,Klotho Neurosciences Inc C/Wts 21/06/2029 、Chimerix, Inc.、Silexion Therapeutics Corp涨幅较大,Silexion Therapeutics Corp、Tc Biopharm Plc、Zyversa Therapeutics, Inc.较为活跃,换手率分别为310.54%、251.30%、183.65%,振幅较大的相关个股有4D Molecular Therapeutics, Inc.、Plus Therapeutics, Inc.、Zura Bio Limited,振幅分别为8.56%、6.59%、5.61%。Traws Pharma, Inc.公司简介:Traws Pharma Inc 是一家生物制药公司,专注于开发流感、COVID和其他呼吸道感染的抗病毒药物和narazaciclib。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305223027963adbe6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305223027963adbe6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TRAW","BK4007"],"gpt_icon":0},{"id":"2516632682","title":"Traws Pharma, Inc.盘中异动 股价大跌6.95%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516632682","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516632682?lang=zh_cn&edition=full","pubTime":"2025-03-03 22:34","pubTimestamp":1741012446,"startTime":"0","endTime":"0","summary":"北京时间2025年03月03日22时34分,Traws Pharma, Inc.股票出现异动,股价大幅下跌6.95%。Traws Pharma, Inc.股票所在的生物技术行业中,整体涨幅为0.38%。其相关个股中,Bioxcel Therapeutics, Inc.、Entero Therapeutics Inc.、Alto Neuroscience, Inc.涨幅较大,Allarity Therapeutics, Inc.、Entero Therapeutics Inc.、Bioxcel Therapeutics, Inc.较为活跃,换手率分别为47.66%、28.93%、27.72%,振幅较大的相关个股有Bioxcel Therapeutics, Inc.、Entero Therapeutics Inc.、Spruce Biosciences, Inc.,振幅分别为33.98%、21.22%、19.25%。Traws Pharma, Inc.公司简介:Traws Pharma Inc 是一家生物制药公司,专注于开发流感、COVID和其他呼吸道感染的抗病毒药物和narazaciclib。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303223406989a1018&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303223406989a1018&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TRAW","BK4007"],"gpt_icon":0},{"id":"2514515373","title":"Traws Pharma, Inc.盘中异动 早盘大幅下挫5.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514515373","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514515373?lang=zh_cn&edition=full","pubTime":"2025-02-28 23:05","pubTimestamp":1740755127,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日23时05分,Traws Pharma, Inc.股票出现波动,股价快速跳水5.17%。Traws Pharma, Inc.股票所在的生物技术行业中,整体涨幅为0.31%。其相关个股中,Bioxcel Therapeutics, Inc.、Immunitybio, Inc.、Puma Biotechnology Inc涨幅较大,Bioxcel Therapeutics, Inc.、Enveric Biosciences, Inc.、Virpax Pharmaceuticals, Inc.较为活跃,换手率分别为1009.23%、385.75%、319.45%,振幅较大的相关个股有Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 、Nrx Pharmaceuticals Inc C/Wts 24/05/2026 、Bioxcel Therapeutics, Inc.,振幅分别为46.60%、42.89%、38.73%。Traws Pharma, Inc.公司简介:Traws Pharma Inc 是一家生物制药公司,专注于开发流感、COVID和其他呼吸道感染的抗病毒药物和narazaciclib。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228230527a25809d8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228230527a25809d8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","TRAW"],"gpt_icon":0},{"id":"2514851333","title":"Traws Pharma, Inc.盘中异动 大幅拉升10.00%报3.85美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514851333","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514851333?lang=zh_cn&edition=full","pubTime":"2025-02-26 23:07","pubTimestamp":1740582421,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日23时07分,Traws Pharma, Inc.股票出现异动,股价快速上涨10.00%。截至发稿,该股报3.85美元/股,成交量1503股,换手率0.04%,振幅10.00%。Traws Pharma, Inc.股票所在的生物技术行业中,整体跌幅为0.08%。Traws Pharma, Inc.公司简介:Traws Pharma Inc 是一家生物制药公司,专注于开发流感、COVID和其他呼吸道感染的抗病毒药物和narazaciclib。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226230701abddf581&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226230701abddf581&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","TRAW"],"gpt_icon":0},{"id":"2514090251","title":"Traws Pharma, Inc.盘中异动 早盘股价大涨5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514090251","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514090251?lang=zh_cn&edition=full","pubTime":"2025-02-25 22:38","pubTimestamp":1740494311,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日22时38分,Traws Pharma, Inc.股票出现异动,股价急速拉升5.00%。Traws Pharma, Inc.股票所在的生物技术行业中,整体涨幅为0.05%。其相关个股中,Organovo Holdings, Inc.、Silexion Therapeutics Corp、Gt Biopharma, Inc.涨幅较大,Gt Biopharma, Inc.、Organovo Holdings, Inc.、Moleculin Biotech, Inc.较为活跃,换手率分别为813.36%、582.22%、503.58%,振幅较大的相关个股有Organovo Holdings, Inc.、Gt Biopharma, Inc.、Moleculin Biotech, Inc.,振幅分别为100.27%、33.50%、20.56%。Traws Pharma, Inc.公司简介:Traws Pharma Inc 是一家生物制药公司,专注于开发流感、COVID和其他呼吸道感染的抗病毒药物和narazaciclib。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225223831a25388f8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225223831a25388f8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TRAW","BK4007"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.onconova.com","stockEarnings":[{"period":"1week","weight":0.3729},{"period":"1month","weight":0.8409},{"period":"3month","weight":-0.076},{"period":"6month","weight":0.538},{"period":"1year","weight":-0.559},{"period":"ytd","weight":1.1504}],"compareEarnings":[{"period":"1week","weight":-0.0072},{"period":"1month","weight":0.0008},{"period":"3month","weight":0.0203},{"period":"6month","weight":0.0758},{"period":"1year","weight":0.1366},{"period":"ytd","weight":0.0051}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Traws Pharma, Inc.于1998年12月22日在特拉华州注册成立,于1999年1月1日开始运营,是一家临床阶段的生物制药公司,专注于发现和开发治疗癌症的新型小分子候选药物。Traws正在开发用于流感、COVID和其他呼吸道感染的下一代、同类最佳的抗病毒药物,以及用于肿瘤学的narazaciclib。","yearOnYearQuotes":[{"month":1,"riseRate":0.538462,"avgChangeRate":0.201678},{"month":2,"riseRate":0.416667,"avgChangeRate":-0.076386},{"month":3,"riseRate":0.416667,"avgChangeRate":-0.052994},{"month":4,"riseRate":0.25,"avgChangeRate":-0.132766},{"month":5,"riseRate":0.333333,"avgChangeRate":-0.059914},{"month":6,"riseRate":0.75,"avgChangeRate":0.06745},{"month":7,"riseRate":0.25,"avgChangeRate":-0.019463},{"month":8,"riseRate":0.230769,"avgChangeRate":-0.120142},{"month":9,"riseRate":0.384615,"avgChangeRate":-0.103896},{"month":10,"riseRate":0.230769,"avgChangeRate":-0.080722},{"month":11,"riseRate":0.461538,"avgChangeRate":-0.058331},{"month":12,"riseRate":0.307692,"avgChangeRate":0.009577}],"exchange":"NASDAQ","name":"TRAWS PHARMA","nameEN":"TRAWS PHARMA"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"TRAWS PHARMA(TRAW)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供TRAWS PHARMA(TRAW)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"TRAWS PHARMA,TRAW,TRAWS PHARMA股票,TRAWS PHARMA股票老虎,TRAWS PHARMA股票老虎国际,TRAWS PHARMA行情,TRAWS PHARMA股票行情,TRAWS PHARMA股价,TRAWS PHARMA股市,TRAWS PHARMA股票价格,TRAWS PHARMA股票交易,TRAWS PHARMA股票购买,TRAWS PHARMA股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"TRAWS PHARMA(TRAW)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供TRAWS PHARMA(TRAW)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}